On the MTD paradigm and optimal control for multi-drug cancer chemotherapy
From MaRDI portal
(Redirected from Publication:356954)
Recommendations
- A review of optimal chemotherapy protocols: from MTD towards metronomic therapy
- On optimal chemotherapy for heterogeneous tumors
- On drug resistance and metronomic chemotherapy: a mathematical modeling and optimal control approach
- A 3-compartment model for chemotherapy of heterogeneous tumor populations
- The influence of PK/PD on the structure of optimal controls in cancer chemotherapy models
Cited in
(16)- Fields of extremals and sensitivity analysis for multi-input bilinear optimal control problems
- Sufficient conditions for strong local optimality in optimal control problems with \(L_{2}\)-type objectives and control constraints
- On drug resistance and metronomic chemotherapy: a mathematical modeling and optimal control approach
- Evaluating the efficacies of maximum tolerated dose and metronomic chemotherapies: a mathematical approach
- Optimal Chemotherapy for Brain Tumor Growth in a Reaction-Diffusion Model
- Optimizing the delivery of combination therapy for tumors: A mathematical model
- Is maximum tolerated dose (MTD) chemotherapy scheduling optimal for glioblastoma multiforme?
- Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis
- A 3-compartment model for chemotherapy of heterogeneous tumor populations
- Dynamics and optimal control of chemotherapy for low grade gliomas: insights from a mathematical model
- Limiting the development of anti-cancer drug resistance in a spatial model of micrometastases
- The structure of optimal protocols for a mathematical model of chemotherapy with antiangiogenic effects
- A review of optimal chemotherapy protocols: from MTD towards metronomic therapy
- Influence of mutations in phenotypically-structured populations in time periodic environment
- Optimal treatments for photodynamic therapy
- Optimal control problems for differential equations applied to tumor growth: state of the art
This page was built for publication: On the MTD paradigm and optimal control for multi-drug cancer chemotherapy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q356954)